We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-8.86%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$220M
AUM Growth
-$17M
Cap. Flow
-$6.31M
Cap. Flow %
-2.87%
Top 10 Hldgs %
36.95%
Holding
108
New
33
Increased
19
Reduced
16
Closed
31

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.56M
2
ABT icon
Abbott
ABT
+$4.95M
3
AET
Aetna Inc
AET
+$4.28M
4
ATHN
Athenahealth, Inc.
ATHN
+$4.12M
5
SHPG
Shire pic
SHPG
+$3.89M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$8.41M
2
BRKR icon
Bruker
BRKR
+$6.43M
3
TFX icon
Teleflex
TFX
+$5.58M
4
LIVN icon
LivaNova
LIVN
+$4.01M
5
NUVA
NuVasive, Inc.
NUVA
+$3.63M

Sector Composition

Rank Sector Weight
1 Healthcare 59.86%
2 Financials 2.04%
3 Industrials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBAY
76
DELISTED
Cymabay Therapeutics
CBAY
$76K 0.03%
56,000
-144,000
-72% -$178K
OCUL icon
77
Ocular Therapeutix
OCUL
$2.14B
$58K 0.03%
+6,000
New +$45.4K
ARAY icon
78
CALL
Accuray
ARAY
$34.6M
– –
-100,000
Closed -$675K
AVNS
79
DELISTED
Avanos Medical
AVNS
– –
-44,573
Closed -$1.49M
AZN icon
80
PUT
AstraZeneca
AZN
$246B
– –
-46,250
Closed -$8.63M
BAX icon
81
CALL
Baxter International
BAX
$14.3B
– –
-100,000
Closed -$3.81M
BDX icon
82
PUT
Becton Dickinson
BDX
$49.4B
– –
-30,750
Closed -$4.62M
BMRN icon
83
PUT
BioMarin Pharmaceuticals
BMRN
$13.5B
– –
-56,000
Closed -$5.87M
BRKR icon
84
Bruker
BRKR
$8.69B
– –
-265,000
Closed -$6.43M
CAH icon
85
PUT
Cardinal Health
CAH
$56.3B
– –
-35,000
Closed -$3.12M
CI icon
86
Cigna
CI
$72.4B
– –
-57,500
Closed -$8.41M
COO icon
87
Cooper Companies
COO
$15B
– –
-100,000
Closed -$3.35M
COO icon
88
PUT
Cooper Companies
COO
$15B
– –
-100,000
Closed -$3.35M
EW icon
89
CALL
Edwards Lifesciences
EW
$54B
– –
-150,000
Closed -$3.95M
HCA icon
90
PUT
HCA Healthcare
HCA
$89.1B
– –
-45,000
Closed -$3.04M
IBB icon
91
PUT
iShares Biotechnology ETF
IBB
$9.81B
– –
-54,000
Closed -$6.09M
KALV
92
DELISTED
KalVista Pharmaceuticals
KALV
– –
-5,714
Closed -$290K
LIVN icon
93
LivaNova
LIVN
$4.33B
– –
-67,500
Closed -$4.01M
RMD icon
94
PUT
ResMed
RMD
$32.6B
– –
-50,000
Closed -$2.69M
SRPT icon
95
CALL
Sarepta Therapeutics
SRPT
$1.92B
– –
-5,400
Closed -$208K
SYK icon
96
Stryker
SYK
$134B
– –
-22,500
Closed -$2.09M
TFX icon
97
CALL
Teleflex
TFX
$5.91B
– –
-50,000
Closed -$6.57M
TNDM icon
98
Tandem Diabetes Care
TNDM
$1.63B
– –
-8,287
Closed -$979K
XBI icon
99
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
– –
-85,000
Closed -$5.97M
XLI icon
100
PUT
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
– –
-65,000
Closed -$3.45M
1 2 3
4
5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2016 Portfolio in Review

As of Q1 2016, Pura Vida Investments held 108 positions worth $220M, down 7.2% from $237M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments's Q1 2016 filing shows 33 new, 19 increased, 16 reduced and 31 closed positions. Its largest new stake was Abbott: 125,000 shares worth $5.23M. The largest sale was Cigna, an estimated $8.41M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Financials and Industrials.

  • Pura Vida Investments's largest Q1 2016 buy was Abbott: 125,000 shares worth $5.23M.
  • Pura Vida Investments added most to Allergan plc in Q1 2016, an estimated $8.56M increase.
  • Pura Vida Investments's biggest Q1 2016 reduction was Teleflex, cutting an estimated $5.58M.
  • Pura Vida Investments fully exited Cigna in Q1 2016, selling an estimated $8.41M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $220M portfolio in Q1 2016.
  • Pura Vida Investments opened 33 new positions and closed 31 in Q1 2016.
  • Pura Vida Investments's portfolio value fell 7.2% quarter-over-quarter to $220M.

Based on Pura Vida Investments's 13F filing for Q1 2016, filed 16 May 2016.